24 results
424B3
PTPI
Petros Pharmaceuticals Inc
19 Sep 23
Prospectus supplement
4:36pm
price of any Warrants not exercised by the selling stockholders on a cashless exercise basis. We will bear all fees and expenses incident to our
8-K
EX-10.2
96otxbw9ctlff2bw08xt
13 Jul 23
Petros Pharmaceuticals Announces Capital Raise of $15 million
4:41pm
POS AM
wf61r3syja7ej5af8
14 Oct 22
Prospectus update (post-effective amendment)
4:05pm
424B3
buua8jxvkl
14 Jan 22
Prospectus supplement
5:18pm
8-K
EX-10.1
jsu1es5dg15 e2n
27 Dec 21
Petros Pharmaceuticals Announces $7.5 Million Offering
5:02pm
424B3
4st dpnhbmdct
20 Dec 21
Prospectus supplement
7:24am
8-K
EX-10.1
4g04w4fjampkwni
1 Dec 21
Petros Pharmaceuticals Announces $10 Million Offering
5:12pm
424B3
uh1e09dnon88urn
23 Nov 21
Prospectus supplement
4:11pm
S-1
1scoll ebc66auhgbqf
12 Nov 21
IPO registration
5:03pm
8-K
EX-10.1
ckc2exz9wlw
15 Oct 21
Petros Pharmaceuticals Announces $5.7 Million Registered Direct Offering
5:03pm
10-K
5i8m6 j97ilj
31 Mar 21
Annual report
4:30pm
8-K
EX-3.2
cgwszb9d
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am